Irinotecan Hydrochloride Injection
Product Images NDC 68083-382

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Irinotecan Hydrochloride (NDC 68083-382). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Irinotecan Spl Carton 2 mL

This text is a description of a drug called "Irinotecan Hydrochloride Injection, USP". It is used for intravenous use only and has to be diluted before use. It contains 40 mg/2 mL of irinotecan. The text provides storage instructions, dosage and use information, and a warning about its cytotoxicity. There are also manufacturing details and codes provided.*

FDA Label Image

Irinotecan Spl Carton 5 mL

This text describes a medication called Irinotecan Hydrochloride which is meant for intravenous use only. It is a cytotoxic agent and comes in a 5mL single dose vial with a strength of 100 mg/5ml. The contents should be diluted before use and caution must be taken while handling. The package code is APIORUGST32011 and it has been manufactured by Prama L in T Visairapaan. It is NDCB08338201 and is available only with a prescription.*

FDA Label Image

Irinotecan Spl Container 2 mL

This is a description of a pharmaceutical product labeled with the National Drug Code 68083-381-01 for Rx Only use. The product is an Injection of Irinotecan Hydrochloride, which is a cytotoxic agent used for intravenous use only. The Injection comes in a 2mL single-dose vial containing 40 mg/2 mL of Irinotecan Hydrochloride, which must be diluted before use. The text also provides cautionary information regarding the toxicity of the drug.*

FDA Label Image

Irinotecan Spl Container 5 mL

This is a label for a medication called Irinotecan Hydrochloride Injection. The medication is a cytotoxic agent that must be diluted before being administered intravenously. It comes in a single dose vial of 5mL with a strength of 100mg/5 (20mg/mL). The label also includes some additional characters and numbers of unclear meaning.*

FDA Label Image

Irinotecan Spl Figure 1

FDA Label Image

Irinotecan Spl Figure 2

FDA Label Image

Irinotecan-spl-figure-3 (Irinotecan Spl Figure 3)

FDA Label Image

Irinotecan-spl-figure-4 (Irinotecan Spl Figure 4)

This appears to be a medical report with limited information. The text mentions "Probability" and "Innotecan 5-FU" which may indicate a treatment plan for a medical condition. The numbers "N 127 129" and "Median follow-up 15 mo" suggest that the report is based on a study or clinical trial involving 127 to 129 participants, with a median follow-up period of 15 months. The final line "Median (mo)" may indicate that the study has a median time point for certain measurements, but without further context, it is difficult to determine the exact meaning.*

FDA Label Image

Irinotecan-spl-structure (Irinotecan Spl Structure)

I'm sorry, but "Irinotecan Hydrochioride" is not enough information to generate a useful description. It seems to be a misspelling of "Irinotecan Hydrochloride," which is a chemotherapy medication used to treat certain types of cancer. However, I cannot provide more information without additional context or text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.